Briefing: Heart failure is common. A quick MRI could improve diagnosis and guide treatment
Strategic angle: A new MRI method measures cardiac oxygen use in three minutes without catheters or radiation, offering a simpler way to study heart failure and metabolism.
Briefing: A leadership vacuum adds to strains on the CDC
Strategic angle: Low morale, staff turnover and budget issues have sapped the Centers for Disease Control and Prevention. The administration is expected to soon name a new director, who will have their hands full.
Briefing: France overexposed to heavy metal cadmium due to food
Strategic angle: The French Agency for Food, Environmental and Occupational Health & Safety warns the government about high cadmium levels in food.
Briefing: Deaths and Health Care Issues in ICE Detention Centers Under the Second Trump Administration
Strategic angle: An overview of deaths in ICE custody and health care issues during the Trump administration.
Briefing: Federal vaccine adviser departs ACIP
Strategic angle: Robert Malone, an outspoken doctor and ally of RFK Jr., is stepping away from a panel of federal vaccine advisers after a federal judge blocked the panel’s work.
Briefing: A tiny protein tweak, finally traceable: How light-based tagging targets pyroglutamate
Strategic angle: Amino acids are like Lego blocks—they can be linked together to form complex structures called proteins.
Briefing: The man who coined Metaverse now says Meta's glasses are creepy
Strategic angle: Neal Stephenson expresses concerns about Meta's virtual reality technology.
Briefing: US public health groups urge firing of EPA boss Zeldin, saying he ‘brazenly betrayed’ agency
Strategic angle: Advocates claim Lee Zeldin’s EPA has compromised health protections and reduced resources.
Briefing: Who wins what in the EU's new trade deal with Australia?
Strategic angle: Squeezed by Trump's tariffs and China's industrial muscle, the EU and Australia bury old trade disputes to finalize a long-delayed free trade deal.
Briefing: STAT+: How will Trump handle the CDC and ACIP?
Strategic angle: Trump's decisions serve as a test of how much sway RFK Jr.'s MAHA movement still has in the White House.
Briefing: Who is Trump talking to in Iran?
Strategic angle: US President Donald Trump has postponed his threat to bomb Iran's energy infrastructure, claiming Tehran wants to negotiate a deal with Washington.
Briefing: Pharmalittle: Trump Drug Pricing Flaw and Gilead Deal Insights
Strategic angle: Comments from a top Trump administration health official highlight significant issues in the president’s drug pricing plans.
Briefing: New lipid nanoparticle design improves precision of mRNA vaccine delivery
Strategic angle: Penn Engineers have redesigned a key component of lipid nanoparticles to enhance targeting and reduce off-target effects.
Briefing: 5 ways to protect your health when air pollution spikes
Strategic angle: Small changes to your routine can cut your exposure more than you might think.
Briefing: The potential loophole in Trump’s plan to get other countries to pay more for drugs
Strategic angle: Diverging messages on the main effort to address U.S. drug prices point to a loophole in Trump's plan.
Briefing: Europe misses 1 out of 5 tuberculosis cases as drug resistance rises, health agencies warn
Strategic angle: Tuberculosis remains a public health issue in Europe as the region is falling behind elimination targets, according to a new report by the World Health Organization and the European Centre for Disease Prevention and Control.
Briefing: Adding 1,000 immigrants tied to 142 more health workers, fewer elderly deaths
Strategic angle: New research finds that an influx of immigrants can significantly reduce elderly mortality rates in metropolitan areas.
Briefing: Mining a methane-degrading bioreactor for protein rubies
Strategic angle: Scientists discover a new iron-storing protein in methane-degrading microbes, highlighting the need for characterizing hard-to-isolate proteins.
Briefing: Epic Uncovers Issues in Patient Record Sharing, Calls for HHS Action
Strategic angle: A recent lawsuit by Epic reveals a company allegedly posing as a provider to access patient records, raising concerns over oversight.
Iran war has not disrupted pharma supply chains. That could change if conflict is prolonged
The escalating war in the Middle East so far has not appreciably disrupted global pharmaceutical supply chains, but it could eventually — affecting prices.